Access the full text.
Sign up today, get DeepDyve free for 14 days.
( Mohr SE . First in Fly: Drosophila Research and Biological Discovery. Harvard University Press; 2018.)
Mohr SE . First in Fly: Drosophila Research and Biological Discovery. Harvard University Press; 2018.Mohr SE . First in Fly: Drosophila Research and Biological Discovery. Harvard University Press; 2018., Mohr SE . First in Fly: Drosophila Research and Biological Discovery. Harvard University Press; 2018.
( Tong JJ , Schriner SE , McCleary D , Day BJ , Wallace DC . Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis‐1 in Drosophila melanogaster . Nat Genet. 2007;39(4):476‐485.17369827)
Tong JJ , Schriner SE , McCleary D , Day BJ , Wallace DC . Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis‐1 in Drosophila melanogaster . Nat Genet. 2007;39(4):476‐485.17369827Tong JJ , Schriner SE , McCleary D , Day BJ , Wallace DC . Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis‐1 in Drosophila melanogaster . Nat Genet. 2007;39(4):476‐485.17369827, Tong JJ , Schriner SE , McCleary D , Day BJ , Wallace DC . Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis‐1 in Drosophila melanogaster . Nat Genet. 2007;39(4):476‐485.17369827
( Savitsky M , Solis GP , Kryuchkov M , Katanaev VL . Humanization of Drosophila Gαo to model GNAO1 paediatric encephalopathies. Biomedicine. 2020;8(10):395.)
Savitsky M , Solis GP , Kryuchkov M , Katanaev VL . Humanization of Drosophila Gαo to model GNAO1 paediatric encephalopathies. Biomedicine. 2020;8(10):395.Savitsky M , Solis GP , Kryuchkov M , Katanaev VL . Humanization of Drosophila Gαo to model GNAO1 paediatric encephalopathies. Biomedicine. 2020;8(10):395., Savitsky M , Solis GP , Kryuchkov M , Katanaev VL . Humanization of Drosophila Gαo to model GNAO1 paediatric encephalopathies. Biomedicine. 2020;8(10):395.
Paul Marcogliese, Samantha Deal, Jonathan Andrews, J. Harnish, V. Bhavana, Hillary Graves, Sharayu Jangam, Xi Luo, Ning Liu, Danqing Bei, Y. Chao, Brooke Hull, Pei-Tseng Lee, Hongling Pan, Pradnya Bhadane, Mei-Chu Huang, Colleen Longley, Hsiao-Tuan Chao, Hyung-Lok Chung, Nele Haelterman, Oguz Kanca, S. Manivannan, L. Rossetti, Ryan German, A. Gerard, E. Schwaibold, S. Fehr, R. Guerrini, A. Vetro, E. England, C. Murali, T. Barakat, M. Dooren, M. Wilke, M. Slegtenhorst, G. Lesca, I. Sabatier, N. Chatron, C. Brownstein, Jill Madden, P. Agrawal, B. Keren, T. Courtin, L. Perrin, Melanie Brugger, T. Roser, S. Leiz, F. Mau-Them, J. Delanne, E. Sukarova-Angelovska, S. Trajkova, Erik Rosenhahn, V. Strehlow, K. Platzer, Roberto Keller, Lisa Pavinato, A. Brusco, J. Rosenfeld, Ronit Marom, Michael Wangler, Shinya Yamamoto (2022)
Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseasesCell reports, 38
( Kachroo AH , Laurent JM , Yellman CM , Meyer AG , Wilke CO , Marcotte EM . Systematic humanization of yeast genes reveals conserved functions and genetic modularity. Science. 2015;348(6237):921‐925.25999509)
Kachroo AH , Laurent JM , Yellman CM , Meyer AG , Wilke CO , Marcotte EM . Systematic humanization of yeast genes reveals conserved functions and genetic modularity. Science. 2015;348(6237):921‐925.25999509Kachroo AH , Laurent JM , Yellman CM , Meyer AG , Wilke CO , Marcotte EM . Systematic humanization of yeast genes reveals conserved functions and genetic modularity. Science. 2015;348(6237):921‐925.25999509, Kachroo AH , Laurent JM , Yellman CM , Meyer AG , Wilke CO , Marcotte EM . Systematic humanization of yeast genes reveals conserved functions and genetic modularity. Science. 2015;348(6237):921‐925.25999509
V. Katanaev, A. Tomlinson (2006)
Dual roles for the trimeric G protein Go in asymmetric cell division in Drosophila.Proceedings of the National Academy of Sciences of the United States of America, 103 17
( Paylor R , Hirotsune S , Gambello MJ , Yuva‐Paylor L , Crawley JN , Wynshaw‐Boris A . Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn Mem. 1999;6(5):521‐537.10541472)
Paylor R , Hirotsune S , Gambello MJ , Yuva‐Paylor L , Crawley JN , Wynshaw‐Boris A . Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn Mem. 1999;6(5):521‐537.10541472Paylor R , Hirotsune S , Gambello MJ , Yuva‐Paylor L , Crawley JN , Wynshaw‐Boris A . Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn Mem. 1999;6(5):521‐537.10541472, Paylor R , Hirotsune S , Gambello MJ , Yuva‐Paylor L , Crawley JN , Wynshaw‐Boris A . Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn Mem. 1999;6(5):521‐537.10541472
Y. Lei, R. Warrior (2000)
The Drosophila Lissencephaly1 (DLis1) gene is required for nuclear migration.Developmental biology, 226 1
N. Mboi, Indra Surbakti, Indang Trihandini, I. Elyazar, Karen Smith, Pungkas Ali, S. Kosen, Kristin Flemons, S. Ray, Jackie Cao, Scott Glenn, M. Miller-Petrie, M. Mooney, J. Ried, Dina Ningrum, Fachmi Idris, K. Siregar, P. Harimurti, R. Bernstein, Tikki Pangestu, Y. Sidharta, M. Naghavi, C. Murray, S. Hay (2018)
On the road to universal health care in Indonesia, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet (London, England), 392
V. Katanaev, J. Valnohova, D. Silachev, Y. Larasati, A. Koval (2023)
Pediatric GNAO1 encephalopathies: from molecular etiology of the disease to drug discoveryNeural Regeneration Research, 18
A. Wynshaw-Boris, T. Pramparo, Y. Youn, S. Hirotsune (2010)
Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies.Seminars in cell & developmental biology, 21 8
( Solis GP , Kozhanova TV , Koval A , et al. Pediatric encephalopathy: clinical, biochemical and cellular insights into the role of Gln52 of GNAO1 and GNAI1 for the dominant disease. Cells. 2021;10(10):2749.34685729)
Solis GP , Kozhanova TV , Koval A , et al. Pediatric encephalopathy: clinical, biochemical and cellular insights into the role of Gln52 of GNAO1 and GNAI1 for the dominant disease. Cells. 2021;10(10):2749.34685729Solis GP , Kozhanova TV , Koval A , et al. Pediatric encephalopathy: clinical, biochemical and cellular insights into the role of Gln52 of GNAO1 and GNAI1 for the dominant disease. Cells. 2021;10(10):2749.34685729, Solis GP , Kozhanova TV , Koval A , et al. Pediatric encephalopathy: clinical, biochemical and cellular insights into the role of Gln52 of GNAO1 and GNAI1 for the dominant disease. Cells. 2021;10(10):2749.34685729
( Chang JC , Morton DB . Drosophila lines with mutant and wild type human TDP‐43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects. PLoS ONE. 2017;12(7):e0180828.28686708)
Chang JC , Morton DB . Drosophila lines with mutant and wild type human TDP‐43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects. PLoS ONE. 2017;12(7):e0180828.28686708Chang JC , Morton DB . Drosophila lines with mutant and wild type human TDP‐43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects. PLoS ONE. 2017;12(7):e0180828.28686708, Chang JC , Morton DB . Drosophila lines with mutant and wild type human TDP‐43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects. PLoS ONE. 2017;12(7):e0180828.28686708
Mckenna Kelly, Meredith Park, I. Mihalek, A. Rochtus, Marie Gramm, Eduardo Pérez-Palma, Erika Axeen, C. Hung, H. Olson, L. Swanson, I. Anselm, Lauren Briere, F. High, D. Sweetser, Saima Kayani, M. Snyder, S. Calvert, I. Scheffer, E. Yang, J. Waugh, Dennis Lal, O. Bodamer, A. Poduri (2019)
Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate–binding regionEpilepsia, 60
( Jacks T , Shih TS , Schmitt EM , Bronson RT , Bernards A , Weinberg RA . Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet. 1994;7(3):353‐361.7920653)
Jacks T , Shih TS , Schmitt EM , Bronson RT , Bernards A , Weinberg RA . Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet. 1994;7(3):353‐361.7920653Jacks T , Shih TS , Schmitt EM , Bronson RT , Bernards A , Weinberg RA . Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet. 1994;7(3):353‐361.7920653, Jacks T , Shih TS , Schmitt EM , Bronson RT , Bernards A , Weinberg RA . Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet. 1994;7(3):353‐361.7920653
V. Katanaev, R. Ponzielli, M. Sémériva, A. Tomlinson (2005)
Trimeric G Protein-Dependent Frizzled Signaling in DrosophilaCell, 120
Elizabeth Lewis, Gaynor Smith (2016)
Using Drosophila models of Huntington's disease as a translatable toolJournal of Neuroscience Methods, 265
S. Mohr (2018)
First in Fly: Drosophila Research and Biological DiscoveryScience, 359
Anne-Marie Lüchtenborg, V. Katanaev (2014)
Lack of evidence of the interaction of the Aβ peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's diseaseMolecular Brain, 7
I. The, G. Hannigan, G. Cowley, S. Reginald, Y. Zhong, J. Gusella, I. Hariharan, A. Bernards (1997)
Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.Science, 276 5313
( Nakamura K , Kodera H , Akita T , et al. De novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet. 2013;93(3):496‐505.23993195)
Nakamura K , Kodera H , Akita T , et al. De novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet. 2013;93(3):496‐505.23993195Nakamura K , Kodera H , Akita T , et al. De novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet. 2013;93(3):496‐505.23993195, Nakamura K , Kodera H , Akita T , et al. De novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet. 2013;93(3):496‐505.23993195
( Patel J , Panicker N , Dawson VL , Dawson TM . Cell biology of parkin: clues to the development of new therapeutics for Parkinson's disease. CNS Drugs. 2022;36(12):1249‐1267.36378485)
Patel J , Panicker N , Dawson VL , Dawson TM . Cell biology of parkin: clues to the development of new therapeutics for Parkinson's disease. CNS Drugs. 2022;36(12):1249‐1267.36378485Patel J , Panicker N , Dawson VL , Dawson TM . Cell biology of parkin: clues to the development of new therapeutics for Parkinson's disease. CNS Drugs. 2022;36(12):1249‐1267.36378485, Patel J , Panicker N , Dawson VL , Dawson TM . Cell biology of parkin: clues to the development of new therapeutics for Parkinson's disease. CNS Drugs. 2022;36(12):1249‐1267.36378485
( Berdyński M , Miszta P , Safranow K , et al. SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci Rep. 2022;12(1):103.34996976)
Berdyński M , Miszta P , Safranow K , et al. SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci Rep. 2022;12(1):103.34996976Berdyński M , Miszta P , Safranow K , et al. SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci Rep. 2022;12(1):103.34996976, Berdyński M , Miszta P , Safranow K , et al. SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci Rep. 2022;12(1):103.34996976
( Pilz DT , Matsumoto N , Minnerath S , et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet. 1998;7(13):2029‐2037.9817918)
Pilz DT , Matsumoto N , Minnerath S , et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet. 1998;7(13):2029‐2037.9817918Pilz DT , Matsumoto N , Minnerath S , et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet. 1998;7(13):2029‐2037.9817918, Pilz DT , Matsumoto N , Minnerath S , et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet. 1998;7(13):2029‐2037.9817918
M. Berdyński, P. Miszta, K. Safranow, P. Andersen, M. Morita, S. Filipek, C. Żekanowski, M. Kuźma-Kozakiewicz (2022)
SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severityScientific Reports, 12
( Mata IF , Lockhart PJ , Farrer MJ . Parkin genetics: one model for Parkinson's disease. Hum Mol Genet. 2004;13 Spec No 1:R127‐R133.14976155)
Mata IF , Lockhart PJ , Farrer MJ . Parkin genetics: one model for Parkinson's disease. Hum Mol Genet. 2004;13 Spec No 1:R127‐R133.14976155Mata IF , Lockhart PJ , Farrer MJ . Parkin genetics: one model for Parkinson's disease. Hum Mol Genet. 2004;13 Spec No 1:R127‐R133.14976155, Mata IF , Lockhart PJ , Farrer MJ . Parkin genetics: one model for Parkinson's disease. Hum Mol Genet. 2004;13 Spec No 1:R127‐R133.14976155
A. Fry, T. Cushion, D. Pilz (2014)
The genetics of lissencephalyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 166
( Khotimchenko YS , Silachev DN , Katanaev VL . Marine natural products from the Russian Pacific as sources of drugs for neurodegenerative diseases. Mar Drugs. 2022;20(11):708.36421986)
Khotimchenko YS , Silachev DN , Katanaev VL . Marine natural products from the Russian Pacific as sources of drugs for neurodegenerative diseases. Mar Drugs. 2022;20(11):708.36421986Khotimchenko YS , Silachev DN , Katanaev VL . Marine natural products from the Russian Pacific as sources of drugs for neurodegenerative diseases. Mar Drugs. 2022;20(11):708.36421986, Khotimchenko YS , Silachev DN , Katanaev VL . Marine natural products from the Russian Pacific as sources of drugs for neurodegenerative diseases. Mar Drugs. 2022;20(11):708.36421986
( Lewis EA , Smith GA . Using Drosophila models of Huntington's disease as a translatable tool. J Neurosci Methods. 2016;265:89‐98.26241927)
Lewis EA , Smith GA . Using Drosophila models of Huntington's disease as a translatable tool. J Neurosci Methods. 2016;265:89‐98.26241927Lewis EA , Smith GA . Using Drosophila models of Huntington's disease as a translatable tool. J Neurosci Methods. 2016;265:89‐98.26241927, Lewis EA , Smith GA . Using Drosophila models of Huntington's disease as a translatable tool. J Neurosci Methods. 2016;265:89‐98.26241927
Swagatika Paul, Alicia Pickrell (2021)
Hidden phenotypes of PINK1/Parkin knockout mice.Biochimica et biophysica acta. General subjects
( Lei Y , Warrior R . The Drosophila Lissencephaly1 (DLis1) gene is required for nuclear migration. Dev Biol. 2000;226(1):57‐72.10993674)
Lei Y , Warrior R . The Drosophila Lissencephaly1 (DLis1) gene is required for nuclear migration. Dev Biol. 2000;226(1):57‐72.10993674Lei Y , Warrior R . The Drosophila Lissencephaly1 (DLis1) gene is required for nuclear migration. Dev Biol. 2000;226(1):57‐72.10993674, Lei Y , Warrior R . The Drosophila Lissencephaly1 (DLis1) gene is required for nuclear migration. Dev Biol. 2000;226(1):57‐72.10993674
( Wangler MF , Yamamoto S , Chao HT , et al. Model organisms facilitate rare disease diagnosis and therapeutic research. Genetics. 2017;207(1):9‐27.28874452)
Wangler MF , Yamamoto S , Chao HT , et al. Model organisms facilitate rare disease diagnosis and therapeutic research. Genetics. 2017;207(1):9‐27.28874452Wangler MF , Yamamoto S , Chao HT , et al. Model organisms facilitate rare disease diagnosis and therapeutic research. Genetics. 2017;207(1):9‐27.28874452, Wangler MF , Yamamoto S , Chao HT , et al. Model organisms facilitate rare disease diagnosis and therapeutic research. Genetics. 2017;207(1):9‐27.28874452
( Guo HF , The I , Hannan F , Bernards A , Zhong Y . Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38‐like neuropeptides. Science. 1997;276(5313):795‐798.9115204)
Guo HF , The I , Hannan F , Bernards A , Zhong Y . Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38‐like neuropeptides. Science. 1997;276(5313):795‐798.9115204Guo HF , The I , Hannan F , Bernards A , Zhong Y . Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38‐like neuropeptides. Science. 1997;276(5313):795‐798.9115204, Guo HF , The I , Hannan F , Bernards A , Zhong Y . Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38‐like neuropeptides. Science. 1997;276(5313):795‐798.9115204
H. Bellen, Michael Wangler, Shinya Yamamoto (2019)
The fruit fly at the interface of diagnosis and pathogenic mechanisms of rare and common human diseases.Human molecular genetics
( Larasati YA , Savitsky M , Koval A , Solis GP , Valnohova J , Katanaev VL . Restoration of the GTPase activity and cellular interactions of Gα(o) mutants by Zn(2+) in GNAO1 encephalopathy models. Sci Adv. 2022;8(40):eabn9350.36206333)
Larasati YA , Savitsky M , Koval A , Solis GP , Valnohova J , Katanaev VL . Restoration of the GTPase activity and cellular interactions of Gα(o) mutants by Zn(2+) in GNAO1 encephalopathy models. Sci Adv. 2022;8(40):eabn9350.36206333Larasati YA , Savitsky M , Koval A , Solis GP , Valnohova J , Katanaev VL . Restoration of the GTPase activity and cellular interactions of Gα(o) mutants by Zn(2+) in GNAO1 encephalopathy models. Sci Adv. 2022;8(40):eabn9350.36206333, Larasati YA , Savitsky M , Koval A , Solis GP , Valnohova J , Katanaev VL . Restoration of the GTPase activity and cellular interactions of Gα(o) mutants by Zn(2+) in GNAO1 encephalopathy models. Sci Adv. 2022;8(40):eabn9350.36206333
Guang-Ho Cha, Sunhong Kim, Jeehye Park, Eunji Lee, Myungjin Kim, Sung Lee, J. Kim, Jongkyeong Chung, K. Cho (2005)
Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila.Proceedings of the National Academy of Sciences of the United States of America, 102 29
( Kelly M , Park M , Mihalek I , et al. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate‐binding region. Epilepsia. 2019;60(3):406‐418.30682224)
Kelly M , Park M , Mihalek I , et al. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate‐binding region. Epilepsia. 2019;60(3):406‐418.30682224Kelly M , Park M , Mihalek I , et al. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate‐binding region. Epilepsia. 2019;60(3):406‐418.30682224, Kelly M , Park M , Mihalek I , et al. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate‐binding region. Epilepsia. 2019;60(3):406‐418.30682224
( Marcogliese PC , Deal SL , Andrews J , et al. Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases. Cell Rep. 2022;38(11):110517.35294868)
Marcogliese PC , Deal SL , Andrews J , et al. Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases. Cell Rep. 2022;38(11):110517.35294868Marcogliese PC , Deal SL , Andrews J , et al. Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases. Cell Rep. 2022;38(11):110517.35294868, Marcogliese PC , Deal SL , Andrews J , et al. Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases. Cell Rep. 2022;38(11):110517.35294868
Koichi Iijima, Hsin-Ping Liu, A. Chiang, Stephen Hearn, M. Konsolaki, Y. Zhong (2004)
Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America, 101 17
( Mo J , Moye SL , McKay RM , Le LQ . Neurofibromin and suppression of tumorigenesis: beyond the GAP. Oncogene. 2022;41(9):1235‐1251.35066574)
Mo J , Moye SL , McKay RM , Le LQ . Neurofibromin and suppression of tumorigenesis: beyond the GAP. Oncogene. 2022;41(9):1235‐1251.35066574Mo J , Moye SL , McKay RM , Le LQ . Neurofibromin and suppression of tumorigenesis: beyond the GAP. Oncogene. 2022;41(9):1235‐1251.35066574, Mo J , Moye SL , McKay RM , Le LQ . Neurofibromin and suppression of tumorigenesis: beyond the GAP. Oncogene. 2022;41(9):1235‐1251.35066574
Aashiq Kachroo, J. Laurent, Christopher Yellman, A. Meyer, C. Wilke, E. Marcotte (2015)
Systematic humanization of yeast genes reveals conserved functions and genetic modularityScience, 348
J. Friedman (1999)
Epidemiology of neurofibromatosis type 1.American journal of medical genetics, 89 1
( Koczkowska M , Chen Y , Callens T , et al. Genotype‐phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844‐848. Am J Hum Genet. 2018;102(1):69‐87.29290338)
Koczkowska M , Chen Y , Callens T , et al. Genotype‐phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844‐848. Am J Hum Genet. 2018;102(1):69‐87.29290338Koczkowska M , Chen Y , Callens T , et al. Genotype‐phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844‐848. Am J Hum Genet. 2018;102(1):69‐87.29290338, Koczkowska M , Chen Y , Callens T , et al. Genotype‐phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844‐848. Am J Hum Genet. 2018;102(1):69‐87.29290338
Y. Khotimchenko, D. Silachev, V. Katanaev (2022)
Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative DiseasesMarine Drugs, 20
( The Nervous System . Genes and Disease. National Center for Biotechnology Information (US); 2011.)
The Nervous System . Genes and Disease. National Center for Biotechnology Information (US); 2011.The Nervous System . Genes and Disease. National Center for Biotechnology Information (US); 2011., The Nervous System . Genes and Disease. National Center for Biotechnology Information (US); 2011.
( Bellen HJ , Wangler MF , Yamamoto S . The fruit fly at the interface of diagnosis and pathogenic mechanisms of rare and common human diseases. Hum Mol Genet. 2019;28(R2):R207‐R214.31227826)
Bellen HJ , Wangler MF , Yamamoto S . The fruit fly at the interface of diagnosis and pathogenic mechanisms of rare and common human diseases. Hum Mol Genet. 2019;28(R2):R207‐R214.31227826Bellen HJ , Wangler MF , Yamamoto S . The fruit fly at the interface of diagnosis and pathogenic mechanisms of rare and common human diseases. Hum Mol Genet. 2019;28(R2):R207‐R214.31227826, Bellen HJ , Wangler MF , Yamamoto S . The fruit fly at the interface of diagnosis and pathogenic mechanisms of rare and common human diseases. Hum Mol Genet. 2019;28(R2):R207‐R214.31227826
( Hirotsune S , Fleck MW , Gambello MJ , et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet. 1998;19(4):333‐339.9697693)
Hirotsune S , Fleck MW , Gambello MJ , et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet. 1998;19(4):333‐339.9697693Hirotsune S , Fleck MW , Gambello MJ , et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet. 1998;19(4):333‐339.9697693, Hirotsune S , Fleck MW , Gambello MJ , et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet. 1998;19(4):333‐339.9697693
( Katanaev VL , Egger‐Adam D , Tomlinson A . Antagonistic PCP signaling pathways in the developing Drosophila eye. Sci Rep. 2018;8(1):5741.29636485)
Katanaev VL , Egger‐Adam D , Tomlinson A . Antagonistic PCP signaling pathways in the developing Drosophila eye. Sci Rep. 2018;8(1):5741.29636485Katanaev VL , Egger‐Adam D , Tomlinson A . Antagonistic PCP signaling pathways in the developing Drosophila eye. Sci Rep. 2018;8(1):5741.29636485, Katanaev VL , Egger‐Adam D , Tomlinson A . Antagonistic PCP signaling pathways in the developing Drosophila eye. Sci Rep. 2018;8(1):5741.29636485
( Fry AE , Cushion TD , Pilz DT . The genetics of lissencephaly. Am J Med Genet C Semin Med Genet. 2014;166c(2):198‐210.24862549)
Fry AE , Cushion TD , Pilz DT . The genetics of lissencephaly. Am J Med Genet C Semin Med Genet. 2014;166c(2):198‐210.24862549Fry AE , Cushion TD , Pilz DT . The genetics of lissencephaly. Am J Med Genet C Semin Med Genet. 2014;166c(2):198‐210.24862549, Fry AE , Cushion TD , Pilz DT . The genetics of lissencephaly. Am J Med Genet C Semin Med Genet. 2014;166c(2):198‐210.24862549
( Liu Z , Steward R , Luo L . Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nat Cell Biol. 2000;2(11):776‐783.11056531)
Liu Z , Steward R , Luo L . Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nat Cell Biol. 2000;2(11):776‐783.11056531Liu Z , Steward R , Luo L . Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nat Cell Biol. 2000;2(11):776‐783.11056531, Liu Z , Steward R , Luo L . Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nat Cell Biol. 2000;2(11):776‐783.11056531
( GBD 2016 Neurology Collaborators . Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459‐480.30879893)
GBD 2016 Neurology Collaborators . Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459‐480.30879893GBD 2016 Neurology Collaborators . Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459‐480.30879893, GBD 2016 Neurology Collaborators . Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459‐480.30879893
S. Hirotsune, M. Fleck, M. Gambello, G. Bix, Amy Chen, G. Clark, D. Ledbetter, C. McBain, A. Wynshaw-Boris (1998)
Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethalityNature Genetics, 19
Alcino Silva, P. Frankland, Z. Marowitz, E. Friedman, G. Lazlo, Dianna Cioffi, T. Jacks, R. Bourtchuladze (1997)
A mouse model for the learning and memory deficits associated with neurofibromatosis type INature Genetics, 15
M. Savitsky, Gonzalo Solis, V. Katanaev (2020)
Humanization of Drosophila Gαo to Model GNAO1 Paediatric EncephalopathiesBiomedicines, 8
J. Patel, Nikhil Panicker, V. Dawson, T. Dawson (2022)
Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s DiseaseCNS Drugs, 36
( Wynshaw‐Boris A , Pramparo T , Youn YH , Hirotsune S . Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. Semin Cell Dev Biol. 2010;21(8):823‐830.20688183)
Wynshaw‐Boris A , Pramparo T , Youn YH , Hirotsune S . Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. Semin Cell Dev Biol. 2010;21(8):823‐830.20688183Wynshaw‐Boris A , Pramparo T , Youn YH , Hirotsune S . Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. Semin Cell Dev Biol. 2010;21(8):823‐830.20688183, Wynshaw‐Boris A , Pramparo T , Youn YH , Hirotsune S . Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. Semin Cell Dev Biol. 2010;21(8):823‐830.20688183
Rong Xu, K. Deng, Yi Zhu, Yue Wu, Jing Ren, Min Wan, Shouyuan Zhao, Xiaohui Wu, Min Han, Zhuang Yuan, Tian Xu (2008)
A large-scale functional approach to uncover human genes and pathways in DrosophilaCell Research, 18
Kieran McGovern (1995)
First to Fly
H. Guo, I. The, F. Hannan, A. Bernards, Y. Zhong (1997)
Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides.Science, 276 5313
( Cha GH , Kim S , Park J , et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A. 2005;102(29):10345‐10350.16002472)
Cha GH , Kim S , Park J , et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A. 2005;102(29):10345‐10350.16002472Cha GH , Kim S , Park J , et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A. 2005;102(29):10345‐10350.16002472, Cha GH , Kim S , Park J , et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A. 2005;102(29):10345‐10350.16002472
S. Eaton, T. Wishart (2017)
Bridging the gap: large animal models in neurodegenerative researchMammalian Genome, 28
Zhao Liu, R. Steward, L. Luo (2000)
Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transportNature Cell Biology, 2
D. Silachev, A. Koval, M. Savitsky, G. Padmasola, C. Quairiaux, F. Thorel, V. Katanaev (2022)
Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutationActa Neuropathologica Communications, 10
V. Katanaev, A. Tomlinson (2006)
Multiple Roles of a Trimeric G Protein in Drosophila Cell PolarizationCell Cycle, 5
( Sergeyev AS . On the mutation rate of neurofibromatosis. Humangenetik. 1975;28(2):129‐138.125227)
Sergeyev AS . On the mutation rate of neurofibromatosis. Humangenetik. 1975;28(2):129‐138.125227Sergeyev AS . On the mutation rate of neurofibromatosis. Humangenetik. 1975;28(2):129‐138.125227, Sergeyev AS . On the mutation rate of neurofibromatosis. Humangenetik. 1975;28(2):129‐138.125227
( Silachev D , Koval A , Savitsky M , et al. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation. Acta Neuropathol Commun. 2022;10(1):9.35090564)
Silachev D , Koval A , Savitsky M , et al. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation. Acta Neuropathol Commun. 2022;10(1):9.35090564Silachev D , Koval A , Savitsky M , et al. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation. Acta Neuropathol Commun. 2022;10(1):9.35090564, Silachev D , Koval A , Savitsky M , et al. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation. Acta Neuropathol Commun. 2022;10(1):9.35090564
D. Pilz, N. Matsumoto, S. Minnerath, P. Mills, J. Gleeson, K. Allen, C. Walsh, A. Barkovich, W. Dobyns, D. Ledbetter, M. Ross (1998)
LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation.Human molecular genetics, 7 13
Jer-Cherng Chang, D. Morton (2017)
Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defectsPLoS ONE, 12
Kazuyuki Nakamura, H. Kodera, T. Akita, M. Shiina, Mitsuhiro Kato, H. Hoshino, H. Terashima, H. Osaka, Shinichi Nakamura, J. Tohyama, T. Kumada, T. Furukawa, Satomi Iwata, T. Shiihara, M. Kubota, S. Miyatake, E. Koshimizu, K. Nishiyama, M. Nakashima, Y. Tsurusaki, N. Miyake, K. Hayasaka, K. Ogata, A. Fukuda, N. Matsumoto, H. Saitsu (2013)
De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy.American journal of human genetics, 93 3
Gonzalo Solis, T. Kozhanova, A. Koval, S. Zhilina, T. Mescheryakova, A. Abramov, Evgeny Ishmuratov, E. Bolshakova, K. Osipova, S. Ayvazyan, S. Lebon, I. Kanivets, D. Pyankov, S. Troccaz, D. Silachev, N. Zavadenko, A. Prityko, V. Katanaev (2021)
Pediatric Encephalopathy: Clinical, Biochemical and Cellular Insights into the Role of Gln52 of GNAO1 and GNAI1 for the Dominant DiseaseCells, 10
R. Paylor, S. Hirotsune, M. Gambello, L. Yuva-Paylor, J. Crawley, A. Wynshaw-Boris, A. Wynshaw-Boris (1999)
Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice.Learning & memory, 6 5
V. Katanaev, Mikhail Kryuchkov, Volodymyr Averkov, M. Savitsky, Kseniya Nikolaeva, N. Klimova, S. Khaustov, Gonzalo Solis (2020)
HumanaFly: high-throughput transgenesis and expression of breast cancer transcripts in Drosophila eye discovers the RPS12-Wingless signaling axisScientific Reports, 10
V. Katanaev, Diane Egger‐Adam, A. Tomlinson (2018)
Antagonistic PCP Signaling Pathways in the developing Drosophila eyeScientific Reports, 8
Zhao Liu, T. Xie, R. Steward (1999)
Lis1, the Drosophila homolog of a human lissencephaly disease gene, is required for germline cell division and oocyte differentiation.Development, 126 20
A. Sergeyev (1975)
On the mutation rate of neurofibromatosisHuman Genetics, 28
(2019)
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016, 18
( Hedrich K , Eskelson C , Wilmot B , et al. Distribution, type, and origin of parkin mutations: review and case studies. Mov Disord. 2004;19(10):1146‐1157.15390068)
Hedrich K , Eskelson C , Wilmot B , et al. Distribution, type, and origin of parkin mutations: review and case studies. Mov Disord. 2004;19(10):1146‐1157.15390068Hedrich K , Eskelson C , Wilmot B , et al. Distribution, type, and origin of parkin mutations: review and case studies. Mov Disord. 2004;19(10):1146‐1157.15390068, Hedrich K , Eskelson C , Wilmot B , et al. Distribution, type, and origin of parkin mutations: review and case studies. Mov Disord. 2004;19(10):1146‐1157.15390068
Juan Mo, Stefanie Moye, R. McKay, L. Le (2022)
Neurofibromin and suppression of tumorigenesis: beyond the GAPOncogene, 41
Michael Wangler, Shinya Yamamoto, Hsiao-Tuan Chao, J. Posey, M. Westerfield, J. Postlethwait, P. Hieter, K. Boycott, Philippe Campeau, H. Bellen (2017)
Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic ResearchGenetics, 207
( Luchtenborg AM , Katanaev VL . Lack of evidence of the interaction of the Abeta peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's disease. Mol Brain. 2014;7:81.25387847)
Luchtenborg AM , Katanaev VL . Lack of evidence of the interaction of the Abeta peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's disease. Mol Brain. 2014;7:81.25387847Luchtenborg AM , Katanaev VL . Lack of evidence of the interaction of the Abeta peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's disease. Mol Brain. 2014;7:81.25387847, Luchtenborg AM , Katanaev VL . Lack of evidence of the interaction of the Abeta peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's disease. Mol Brain. 2014;7:81.25387847
James Tong, S. Schriner, David McCleary, B. Day, D. Wallace (2007)
Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogasterNature Genetics, 39
( Paul S , Pickrell AM . Hidden phenotypes of PINK1/parkin knockout mice. Biochim Biophys Acta Gen Subj. 2021;1865(6):129871.33571581)
Paul S , Pickrell AM . Hidden phenotypes of PINK1/parkin knockout mice. Biochim Biophys Acta Gen Subj. 2021;1865(6):129871.33571581Paul S , Pickrell AM . Hidden phenotypes of PINK1/parkin knockout mice. Biochim Biophys Acta Gen Subj. 2021;1865(6):129871.33571581, Paul S , Pickrell AM . Hidden phenotypes of PINK1/parkin knockout mice. Biochim Biophys Acta Gen Subj. 2021;1865(6):129871.33571581
( Friedman JM . Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89(1):1‐6.10469430)
Friedman JM . Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89(1):1‐6.10469430Friedman JM . Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89(1):1‐6.10469430, Friedman JM . Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89(1):1‐6.10469430
( Iijima K , Liu HP , Chiang AS , Hearn SA , Konsolaki M , Zhong Y . Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101(17):6623‐6628.15069204)
Iijima K , Liu HP , Chiang AS , Hearn SA , Konsolaki M , Zhong Y . Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101(17):6623‐6628.15069204Iijima K , Liu HP , Chiang AS , Hearn SA , Konsolaki M , Zhong Y . Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101(17):6623‐6628.15069204, Iijima K , Liu HP , Chiang AS , Hearn SA , Konsolaki M , Zhong Y . Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101(17):6623‐6628.15069204
( Xu R , Deng K , Zhu Y , et al. A large‐scale functional approach to uncover human genes and pathways in Drosophila. Cell Res. 2008;18(11):1114‐1127.18957936)
Xu R , Deng K , Zhu Y , et al. A large‐scale functional approach to uncover human genes and pathways in Drosophila. Cell Res. 2008;18(11):1114‐1127.18957936Xu R , Deng K , Zhu Y , et al. A large‐scale functional approach to uncover human genes and pathways in Drosophila. Cell Res. 2008;18(11):1114‐1127.18957936, Xu R , Deng K , Zhu Y , et al. A large‐scale functional approach to uncover human genes and pathways in Drosophila. Cell Res. 2008;18(11):1114‐1127.18957936
T. Jacks, T. Shih, E. Schmitt, R. Bronson, A. Bernards, R. Weinberg (1994)
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1Nature Genetics, 7
(2011)
Genes and Disease
( Silva AJ , Frankland PW , Marowitz Z , et al. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet. 1997;15(3):281‐284.9054942)
Silva AJ , Frankland PW , Marowitz Z , et al. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet. 1997;15(3):281‐284.9054942Silva AJ , Frankland PW , Marowitz Z , et al. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet. 1997;15(3):281‐284.9054942, Silva AJ , Frankland PW , Marowitz Z , et al. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet. 1997;15(3):281‐284.9054942
B. Keena, Aaina Kochhar, J. Liebelt, A. Martir-Negron, M. Mahoney, I. Maystadt, C. Mcdougall, M. McEntagart, N. Mendelsohn, David Miller, G. Mortier, J. Morton, J. Pappas, S. Plotkin, Dinel Pond, K. Rosenbaum, K. Rubin, L. Russell, Lane Rutledge, V. Saletti, Rhonda Schonberg, A. Schreiber, Meredith Seidel, Elizabeth Siqveland, D. Stockton, E. Trevisson, N. Ullrich, M. Upadhyaya, R. Minkelen, H. Verhelst, M. Wallace, Y. Yap, E. Zackai, J. Zonana, V. Zurcher, K. Claes, Y. Martín, B. Korf, E. Legius, L. Messiaen (2017)
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848American Journal of Human Genetics, 102
I. Mata, P. Lockhart, M. Farrer (2004)
Parkin genetics: one model for Parkinson's disease.Human molecular genetics, 13 Spec No 1
( Eaton SL , Wishart TM . Bridging the gap: large animal models in neurodegenerative research. Mamm Genome. 2017;28(7–8):324‐337.28378063)
Eaton SL , Wishart TM . Bridging the gap: large animal models in neurodegenerative research. Mamm Genome. 2017;28(7–8):324‐337.28378063Eaton SL , Wishart TM . Bridging the gap: large animal models in neurodegenerative research. Mamm Genome. 2017;28(7–8):324‐337.28378063, Eaton SL , Wishart TM . Bridging the gap: large animal models in neurodegenerative research. Mamm Genome. 2017;28(7–8):324‐337.28378063
Koichi Iijima, Hsin-Ping Liu, A. Chiang, Stephen Hearn, M. Konsolaki, Y. Zhong (2004)
Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's diseaseProceedings of the National Academy of Sciences of the United States of America, 101
Y. Larasati, M. Savitsky, A. Koval, Gonzalo Solis, J. Valnohova, V. Katanaev (2022)
Restoration of the GTPase activity and cellular interactions of Gαo mutants by Zn2+ in GNAO1 encephalopathy modelsScience Advances, 8
K. Hedrich, Cordula Eskelson, B. Wilmot, K. Marder, Juliette Harris, J. Garrels, H. Meija-Santana, P. Vieregge, H. Jacobs, S. Bressman, A. Lang, M. Kann, G. Abbruzzese, P. Martinelli, E. Schwinger, L. Ozelius, P. Pramstaller, C. Klein, P. Kramer (2004)
Distribution, type, and origin of Parkin mutations: Review and case studiesMovement Disorders, 19
Neuroscience and neurology research is dominated by experimentation with rodents. Around 75% of neurology disease‐associated genes have orthologs in Drosophila melanogaster, the fruit fly amenable to complex neurological and behavioral investigations. However, non‐vertebrate models including Drosophila have so far been unable to significantly replace mice and rats in this field of studies. One reason for this situation is the predominance of gene overexpression (and gene loss‐of‐function) methodologies used when establishing a Drosophila model of a given neurological disease, a strategy that does not recapitulate accurately enough the genetic disease conditions. I argue here the need for a systematic humanization approach, whereby the Drosophila orthologs of human disease genes are replaced with the human sequences. This approach will identify the list of diseases and the underlying genes that can be adequately modeled in the fruit fly. I discuss the neurological disease genes to which this systematic humanization approach should be applied and provide an example of such an application, and consider its importance for subsequent disease modeling and drug discovery in Drosophila. I argue that this paradigm will not only advance our understanding of the molecular etiology of a number of neurological disorders, but will also gradually enable researchers to reduce experimentation using rodent models of multiple neurological diseases and eventually replace these models.
Animal Models and Experimental Medicine – Wiley
Published: Jun 1, 2023
Keywords: disease modeling; Drosophila; humanization; neurological diseases
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.